3D CT-based high-dose-rate brachytherapy for cervical cancer: clinical impact on late rectal bleeding and local control.

Kang, Hyun-Cheol; Shin, Kyung Hwan; Park, Sung-Yong; Kim, Joo-Young
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
2010Dec ; 97 ( 3 ) :507-13.
ÀúÀÚ »ó¼¼Á¤º¸
Kang, Hyun-Cheol -
Shin, Kyung Hwan -
Park, Sung-Yong -
Kim, Joo-Young -
ABSTRACT
BACKGROUND AND PURPOSE: To identify the impact of 3D CT-based high-dose-rate intracavitary radiotherapy (ICR) on late rectal bleeding (LRB) and local control (LC) in patients with cervical cancer. MATERIAL AND

METHODS: The outcomes of 97 consecutive patients treated with 3D CT-based ICR (3D-ICR) were compared with those of 133 consecutive historical patients with conventional 2D brachytherapy planning (2D-ICR). The median follow-up periods were 41 and 56 months for the 3D and 2D groups, respectively.

RESULTS: The overall rectal bleeding rate was similar between the groups (42% for 3D-ICR vs. 44% for 2D-ICR); however, the incidence of severe LRB was higher in the 2D-ICR group than in the 3D-ICR group (13% vs. 2%, respectively; p=0.02). In multivariate analysis, the factors associated with severe LRB were tumor >4 cm (12% vs. 3%) and 2D-ICR (10% vs. 2%). The LC rates were 97% and 91% for 3D-ICR and 2D-ICR, respectively (p=0.14); the progression-free survival rate was 80% for both groups. A significant difference in the LC rates between the two groups was observed in patients with larger tumor sizes with the tumor diameter of over 4 cm (98% vs. 81% by 3D-ICR vs. 2D-ICR, respectively; p=0.02).

CONCLUSIONS: The implementation of 3D-ICR in radiotherapy for cervical cancer can reduce the incidence of severe LRB and may improve the LC rate. CI - Copyright ??2010 Elsevier Ireland Ltd. All rights reserved.
na
MESH
Adult, Aged, Aged, 80 and over, *Brachytherapy/adverse effects, Disease-Free Survival, Female, Gastrointestinal Hemorrhage/*etiology, Humans, *Imaging, Three-Dimensional, Middle Aged, Organs at Risk/radiation effects, Radiation Injuries/*etiology, Radiotherapy Dosage, Radiotherapy, Conformal, Rectal Diseases/*etiology, *Tomography, X-Ray Computed, Uterine Cervical Neoplasms/pathology/radiography/*radiotherapy, Young Adult
¸µÅ©

ÁÖÁ¦ÄÚµå
ÁÖÁ¦¸í(Target field)
¿¬±¸´ë»ó(Population)
¿¬±¸Âü¿©(Sample size)
´ë»ó¼ºº°(Gender)
Áúº´Æ¯¼º(Condition Category)
¿¬±¸È¯°æ(Setting)
¿¬±¸¼³°è(Study Design)
¿¬±¸±â°£(Period)
ÁßÀç¹æ¹ý(Intervention Type)
ÁßÀç¸íĪ(Intervention Name)
Å°¿öµå(Keyword)
À¯È¿¼º°á°ú(Recomendation)
The overall LC rate at 3 years was 97% for the 3D-ICR group and 91% for the 2D-ICR group. The overall PFS rate at 3 years was 80% for both groups. There was no significant difference between the treatment groups with regard to local control and progression-free survival rates.
¿¬±¸ºñÁö¿ø(Fund Source)
±Ù°Å¼öÁØÆò°¡(Evidence Hierarchy)
ÃâÆdz⵵(Year)
Âü¿©ÀúÀÚ¼ö(Authors)
´ëÇ¥ÀúÀÚ
DOI
10.1016/j.radonc.2010.10.002.
KCDÄÚµå
ICD 03
°Ç°­º¸ÇèÄÚµå